Martin Schicht

Dr. Martin Schicht

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2025 in Cells
Verified
Journal Article
Open access
PDF file
SASophia Auer
Sophia Auer
MSMartin Schicht
Martin Schicht
LHLucas Hoffmann
Lucas Hoffmann
SBSilvia Budday
Silvia Budday
RFRenato Frischknecht
Renato Frischknecht
Friedrich  PaulsenFriedrich Paulsen
Friedrich Paulsen
Perineuronal nets (PNNs) are specialized extracellular matrix structures that predominantly surround inhibitory neurons in the central nervous system (CNS). They have been identified as crucial regulators of synaptic plasticity and neuronal excitability. This literature review aims to summarize the current state of knowledge about PNNs, their molecular composition and structure, as well as their functional roles and involvement in neurological diseases. Furthermore, future directions in PNN research are proposed, and the therapeutic potential of targeting PNNs to develop novel treatment options for various neurological disorders is explored. This review emphasizes the importance of PNNs in CNS physiology and pathology and underscores the need for further research in this area.

21 April 2023 in Science Advances
Verified
Journal Article
Open access
JOJeffrey O'Callaghan
Jeffrey O'Callaghan
CDConor Delaney
Conor Delaney
MOMerissa O’connor
Merissa O’connor
JBJoseph van Batenburg-Sherwood
Joseph van Batenburg-Sherwood
MSMartin Schicht
Martin Schicht
MCMatthew Campbell
Matthew Campbell
Approximately 80 million people globally are affected by glaucoma, with a projected increase to over 110 million by 2040. Substantial issues surrounding patient compliance remain with topical eye drops, and up to 10% of patients become treatment resistant, putting them at risk of permanent vision loss. The major risk factor for glaucoma is elevated intraocular pressure, which is regulated by the balance between the secretion of aqueous humor and the resistance to its flow across the conventional outflow pathway. Here, we show that adeno-associated virus 9 (AAV9)–mediated expression of matrix metalloproteinase-3 (MMP-3) can increase outflow in two murine models of glaucoma and in nonhuman primates. We show that long-term AAV9 transduction of the corneal endothelium in the nonhuman primate is safe and well tolerated. Last, MMP-3 increases outflow in donor human eyes. Collectively, our data suggest that glaucoma can be readily treated with gene therapy–based methods, paving the way for deployment in clinical trials.

3 September 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JWJ. Wittmann
J. Wittmann
JDJ. Dieckow
J. Dieckow
HSH. Schröder
H. Schröder
UHU. Hampel
U. Hampel
FGF. Garreis
F. Garreis
MSMartin Schicht
Martin Schicht
Woundhealing disorders characterized by impaired or delayed re-epithelialization are a serious medical problem that is painful and difficult to treat. Gelsolin (GSN), a known actin modulator, supports epithelial cell regeneration and apoptosis. The aim of this study was to estimate the potential of recombinant gelsolin (rhu-pGSN) for ocular surface regeneration to establish a novel therapy for delayed or complicated wound healing. We analyzed the influence of gelsolin on cell proliferation and wound healing in vitro, in vivo/ex vivo and by gene knockdown. Gelsolin is expressed in all tested tissues of the ocular system as shown by molecular analysis. The concentration of GSN is significantly increased in tear fluid samples of patients with dry eye disease. rhu-pGSN induces cell proliferation and faster wound healing in vitro as well as in vivo/ex vivo. TGF-β dependent transcription of SMA is significantly decreased after GSN gene knockdown. Gelsolin is an inherent protein of the ocular system and is secreted into the tear fluid. Our results show a positive effect on corneal cell proliferation and wound healing. Furthermore, GSN regulates the synthesis of SMA in myofibroblasts, which establishes GSN as a key protein of TGF-β dependent cell differentiation.

28 June 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MSMartin Schicht
Martin Schicht
FGFabian Garreis
Fabian Garreis
NHNadine Hartjen
Nadine Hartjen
SBStephanie Beileke
Stephanie Beileke
CJChristina Jacobi
Christina Jacobi
LBLars Bräuer
Lars Bräuer
The study aimed to characterize the expression and function of SFTA3 at the ocular surface and in tears. Ocular tissues, conjunctival (HCjE) and human corneal (HCE) epithelial cell lines as well as tearfilm of patients suffering from different forms of dry eye disease (DED) were analyzed by means of RT-PCR, western blot, immunohistochemistry, and ELISA. A possible role of recombinant SFTA3 in corneal wound healing was investigated performing in vitro scratch assays. Tear film regulatory properties were analyzed with the spinning drop method and the regulation of SFTA3 transcripts was studied in HCE and HCjE after incubation with proinflammatory cytokines as well as typical ocular pathogens by real-time RT-PCR and ELISA. The results reveal that human ocular tissue as well as tears of healthy volunteers express SFTA3 whereas tears from patients with DED showed significantly increased SFTA3 levels. In vitro wounding of HCE cell cultures that had been treated with recombinant SFTA3 demonstrated a significantly increased wound closure rate and rSFTA3 reduced the surface tension of tear fluid. The results indicate that SFTA3 at the ocular surface seemed to be involved in wound healing and the reduction of surface tension.

21 December 2023 in The Ocular Surface
Verified
Journal Article
Closed access
MSMartin Schicht
Martin Schicht
JFJessica Farger
Jessica Farger
SWSaskia Wedel
Saskia Wedel
MSMarco Sisignano
Marco Sisignano
KSKlaus Scholich
Klaus Scholich
ELElke Lütjen-Drecoll
Elke Lütjen-Drecoll

Verified
Journal Article
Open access
PDF file
KŠKate Šešelja
Kate Šešelja
IBIva Bazina
Iva Bazina
JWJessica Welss
Jessica Welss
MSMartin Schicht
Martin Schicht
Friedrich  PaulsenFriedrich Paulsen
Friedrich Paulsen
Mirela Baus LoncarMirela Baus Loncar
Mirela Baus Loncar
Endoplasmic reticulum (ER) stress, a cellular condition caused by the accumulation of unfolded proteins inside the ER, has been recognized as a major pathological mechanism in a variety of conditions, including cancer, metabolic and neurodegenerative diseases. Trefoil factor family (TFFs) peptides are present in different epithelial organs, blood supply, neural tissues, as well as in the liver, and their deficiency has been linked to the ER function. Complete ablation of Tff3 expression is observed in steatosis, and as the most prominent change in the early phase of diabetes in multigenic mouse models of diabesity. To elucidate the role of Tff3 deficiency on different pathologically relevant pathways, we have developed a new congenic mouse model Tff3−/−/C57BL6/N from a mixed background strain (C57BL6/N /SV129) by using a speed congenics approach. Acute ER stress was evoked by tunicamycin treatment, and mice were sacrificed after 24 h. Afterwards the effect of Tff3 deficiency was evaluated with regard to the expression of relevant oxidative and ER stress genes, relevant proinflammatory cytokines/chemokines, and the global protein content. The most dramatic change was noticed at the level of inflammation-related genes, while markers for unfolded protein response were not significantly affected. Ultrastructural analysis confirmed that the size of lipid vacuoles was affected as well. Since the liver acts as an important metabolic and immunological organ, the influence of Tff3 deficiency and physiological function possibly reflects on the whole organism.